Modern pharmacological therapies and cardiac rehabilitation improve clinical outcomes, functional capacity, and quality of life in patients with heart failure.
This review emphasizes the critical role of integrating cardiac rehabilitation with modern medical therapies, such as SGLT2 inhibitors, in the comprehensive management of heart failure.
, sodium-glucose cotransporter-2 - SGLT2 inhibitors) and such progress in treatment of HFrEF patients resulted in new working definition of the term "HF with recovered left ventricular ejection fraction". In line with rapid development of HF treatment, cardiac rehabilitation becomes an increasingly important part of overall approach to patients with chronic HF for it has been proven that exercise training can relieve symptoms, improve exercise capacity and quality of life as well as reduce disability and hospitalization rates. We gave an overview of latest insights in HF diagnosis and treatment with special emphasize on the important role of cardiac rehabilitation in such patients.
Merkaš et al. (Fri,) conducted a review in Congestive heart failure. Pharmacological therapies and cardiac rehabilitation was evaluated. Modern pharmacological therapies and cardiac rehabilitation improve clinical outcomes, functional capacity, and quality of life in patients with heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: